Today: 14 March 2026
Subscribe
Browse Category

Stock Market 10 December 2025

Cypherpunk Technologies (CYPH) Stock: Zcash Treasury Pivot, Winklevoss Backing and 2026 Forecast Explained

Cypherpunk Technologies (CYPH) Stock: Zcash Treasury Pivot, Winklevoss Backing and 2026 Forecast Explained

Cypherpunk Technologies Inc. (NASDAQ: CYPH), formerly Leap Therapeutics, closed at $1.62 on December 9, 2025, up nearly 40% after pivoting from biotech to a Zcash-focused treasury strategy backed by Winklevoss Capital. The stock has seen trading halts, insider sales, and sharp volatility since the rebrand and $58.88 million private placement in October.
10 December 2025
·····
AMD Stock on December 10, 2025: AI Supercycle, China Risks, and What Wall Street Expects Next

AMD Stock on December 10, 2025: AI Supercycle, China Risks, and What Wall Street Expects Next

AMD shares traded at $221.62 on December 10, 2025, valuing the company at about $361 billion. Q3 revenue rose 36% year over year to $9.25 billion, with net income at $1.24 billion. The stock remains volatile, well above its 52-week low but below its recent high. AMD forecasts over 35% annual revenue growth, driven by AI and data center demand.
10 December 2025
···
EchoStar (SATS) Surges on SpaceX IPO Buzz and Morgan Stanley Upgrade: Latest News, Stock Forecasts and Key Risks (December 10, 2025)

EchoStar (SATS) Surges on SpaceX IPO Buzz and Morgan Stanley Upgrade: Latest News, Stock Forecasts and Key Risks (December 10, 2025)

EchoStar shares rose about 6% to $93.54 by mid-day Wednesday, up over 300% year-to-date, after Morgan Stanley upgraded the stock and raised its price target to $110. The move follows renewed speculation about a 2026 SpaceX IPO, with EchoStar holding $11.1 billion in SpaceX stock. EchoStar’s market cap stands near $27 billion. Analyst ratings range from “Hold” to “Moderate Buy.”
10 December 2025
····
Amazon (AMZN) Stock Today: Price, Fresh Analyst Upgrades, India AI Megabid and 2026 Forecast – December 10, 2025

Amazon (AMZN) Stock Today: Price, Fresh Analyst Upgrades, India AI Megabid and 2026 Forecast – December 10, 2025

Amazon shares traded at $227.92 midday Tuesday, up 0.5%, but have gained just 4–7% in 2025, trailing the S&P 500. Guggenheim initiated coverage with a Buy rating and $300 target. Amazon also announced a $35 billion investment in India focused on AI and exports. The stock sits just below its 50-day average, with technicals showing fading short-term momentum but a long-term uptrend.
10 December 2025
·
Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

Tilray Brands shares surged 12.4% to $8.09 on December 9, 2025, after weeks of steep declines and heavy trading volume. The rebound followed news of a Florida bill to allow home cannabis cultivation and renewed speculation over U.S. federal rescheduling. Tilray remains down 65% from its October high and recently completed a 1-for-10 reverse stock split.
10 December 2025
···
1-800-FLOWERS.COM (FLWS) Stock Jumps 30% on AI-Focused CIO Hire: Latest News, Debt Risk and 2026 Forecast

1-800-FLOWERS.COM (FLWS) Stock Jumps 30% on AI-Focused CIO Hire: Latest News, Debt Risk and 2026 Forecast

1-800-FLOWERS.COM shares jumped 32.8% to $4.94 on December 9, 2025, after naming Alexander Zelikovsky as Chief Information Officer to lead AI and digital commerce initiatives. Trading volume surged to 6.3 million shares. The stock remains down about 46% from its 52-week high, with its balance sheet and earnings still under pressure.
10 December 2025
···
Microsoft Stock (MSFT) on December 10, 2025: $23 Billion AI Bet, Analyst Targets and What It Means for Investors

Microsoft Stock (MSFT) on December 10, 2025: $23 Billion AI Bet, Analyst Targets and What It Means for Investors

Microsoft shares traded near $492 midday, valuing the company at $3.85 trillion, after announcing $23 billion in new AI infrastructure spending across India, Canada, and the U.S. The stock sits about 9% below its October record high. Wall Street targets now reach the mid-$600s, but some analysts warn current prices reflect high optimism. Microsoft reported FY 2025 revenue of $281.7 billion and net income of $101.8 billion.
10 December 2025
···
Twenty One Capital (XXI) Stock: NYSE Debut, Bitcoin Treasury Bet and 2026 Outlook

Twenty One Capital (XXI) Stock: NYSE Debut, Bitcoin Treasury Bet and 2026 Outlook

Twenty One Capital (NYSE: XXI) debuted on the NYSE December 9, 2025, after merging with Cantor Equity Partners. Shares fell nearly 20% on the first day, closing at $11.42 despite the company holding over 43,500 Bitcoin. Early pre-market trading on December 10 showed a slight recovery toward $12.10. Jack Mallers leads the company, with Tether, Bitfinex, and SoftBank as major backers.
10 December 2025
··
CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health raised its 2025–2026 profit outlook and launched an AI-driven engagement platform at its Investor Day in Hartford, sending shares up 2% to around $78 on December 10. The stock has surged nearly 80% year to date. CVS now expects at least $400 billion in 2025 revenue and adjusted EPS of $6.60–$6.70, above prior guidance. Management projects mid-teens adjusted EPS growth through 2028.
10 December 2025
··
Meta Platforms (META) Stock on December 10, 2025: AI Pivot, EU Rulings and New Price Targets

Meta Platforms (META) Stock on December 10, 2025: AI Pivot, EU Rulings and New Price Targets

Meta Platforms traded at $656–$657 per share Wednesday, down 1.5% from the previous close, with a market cap near $1.85 trillion. Shares remain below late-October highs after a sharp drop following Q3 earnings and a surge in AI spending plans. Meta is cutting Reality Labs’ budget by up to 30% and expects to spend about $72 billion on AI in 2025. The company recently invested $14 billion in Scale AI for a 49% stake.
10 December 2025
····
Pan American Silver Stock (PAAS) Hits 12‑Month High as Silver Breaks $60: What Today’s Rally Means for 2026

Pan American Silver Stock (PAAS) Hits 12‑Month High as Silver Breaks $60: What Today’s Rally Means for 2026

Pan American Silver shares hit a 12-month high of $48.78 on December 10, 2025, after jumping 11% the previous day. The surge follows silver’s move above $60 per ounce and anticipation of a Federal Reserve rate cut. Trading volume topped 17 million shares, with the company’s market cap near $20.4 billion. Strong Q3 cash flow, higher production guidance, and recent acquisitions also supported the rally.
10 December 2025
··
Broadcom (AVGO) Stock Near Record High Ahead of Q4 2025 Earnings: AI Supercycle, Analyst Upgrades and 2030 Forecasts

Broadcom (AVGO) Stock Near Record High Ahead of Q4 2025 Earnings: AI Supercycle, Analyst Upgrades and 2030 Forecasts

Broadcom shares traded at $406 on December 10, 2025, just below the 52-week high of $407.29, valuing the company at $1.92 trillion. The company reports fiscal Q4 earnings on December 11, with analysts expecting revenue near $17.5 billion and adjusted EPS of $1.88, both up sharply year over year. AI semiconductor revenue is projected at $6.2 billion, about a third of total sales.
10 December 2025
····
Nvidia (NVDA) Stock Today: Trump’s H200 Green Light, New Chip-Tracking Tech and Fresh 2026 Price Targets

Nvidia (NVDA) Stock Today: Trump’s H200 Green Light, New Chip-Tracking Tech and Fresh 2026 Price Targets

The U.S. government has approved Nvidia to resume sales of its H200 AI chips to select Chinese customers, requiring the company to share 25% of related revenue with Washington. Nvidia shares traded near $185 midday, down slightly but up nearly 40% year-to-date. The new policy does not cover Nvidia’s most advanced chips, which remain restricted. Beijing is considering its response as analysts raise 2026 forecasts.
10 December 2025
···
Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) closed at $4.09 on December 9, down 53.5% from the prior session, after wild swings that saw the stock trade between $4.00 and $7.60 intraday. The company is advancing a Phase 3 trial in a rare inherited cancer syndrome and exploring new financing. Its float remains under 670,000 ADSs, fueling extreme volatility. Market cap stands near $5.5 million.
10 December 2025
··
Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax shares surged as much as 20% on December 10, 2025, in Paris trading amid market rumors of a possible takeover bid by Eli Lilly. The stock hit a 52-week high near €126.60, with market value reaching about €9.7 billion. Abivax declined to comment, and no formal offer has been announced. U.S.-listed ADRs also jumped over 11% in pre-market trading.
10 December 2025
····
JPMorgan Chase (JPM) Stock on December 10, 2025: Expense Shock, Dividend Update and Wall Street Forecasts

JPMorgan Chase (JPM) Stock on December 10, 2025: Expense Shock, Dividend Update and Wall Street Forecasts

JPMorgan Chase shares fell nearly 5% on December 9 after executives projected 2026 expenses of about $105 billion, well above Wall Street estimates. The bank reaffirmed its $1.50 quarterly dividend. As of late morning December 10, shares traded near $300.50, recovering from the sharpest one-day drop in eight months. Analysts remain broadly positive on the stock’s long-term outlook.
10 December 2025
··
Newmont Stock Soars on Gold Rally: Latest NEM News, Analyst Forecasts and 2026 Outlook (10 December 2025)

Newmont Stock Soars on Gold Rally: Latest NEM News, Analyst Forecasts and 2026 Outlook (10 December 2025)

Newmont shares rose 5.7% to $94.09 by mid-day on December 10, with trading volume near 8.7 million. The stock is up over 130% year-to-date, fueled by a surge in gold prices and company restructuring. Newmont sits just below its 52-week high of $98.58 reached in October. Analysts cite strong operational progress and increased mainstream investor interest.
10 December 2025
··
Oracle Stock Today: AI Bets, Debt Fears and What to Watch in Q2 FY26 Earnings

Oracle Stock Today: AI Bets, Debt Fears and What to Watch in Q2 FY26 Earnings

Oracle reports fiscal Q2 2026 earnings after market close, with consensus expecting revenue of $16.2 billion, up 15% year over year, and adjusted EPS of $1.64. Shares traded at $221.53 midday, up about a third in 2025. Options markets imply a 10% swing on the results. Wall Street is watching for signs that Oracle’s AI-driven cloud growth can withstand concerns over debt and customer concentration.
10 December 2025
····
Most Active Stocks Today: Nvidia, Tesla, PAVS, American Airlines and More Drive U.S. Market Volume on December 10, 2025

Most Active Stocks Today: Nvidia, Tesla, PAVS, American Airlines and More Drive U.S. Market Volume on December 10, 2025

Nvidia (NVDA) led U.S. trading volume on December 10, 2025, with about 145 million shares exchanged as the stock hovered near $185. Warner Bros. Discovery (WBD) surged after a $108 billion hostile bid from Paramount Skydance. Microcaps like Paranovus (PAVS) and Senti Biosciences (SNTI) posted sharp volume spikes. Wall Street traded cautiously ahead of the Federal Reserve’s final policy decision of the year.
10 December 2025
1 … 983 984 985 986 987 … 1,349

Stock Market Today

  • Cadre Holdings (CDRE) Shares Drop 27% in a Week - Potential Undervaluation Signals
    March 13, 2026, 11:01 PM EDT. Cadre Holdings (CDRE) saw its share price plunge 27.3% over the past week, extending a 23% year-to-date decline amid volatile trading. Despite this, a Discounted Cash Flow analysis estimates an intrinsic value of $57.23 versus the recent $31.65 share price, indicating the stock could be undervalued by nearly 45%. Cadre, a supplier of safety equipment to law enforcement, has generated $56.6 million in free cash flow over the last twelve months. Analysts forecast growth pushing cash flow to $162.8 million by 2035. The company's valuation score stands at 5 out of 6 on Simply Wall St, suggesting caution but opportunity for investors amid the recent price slump and mixed peer performance.
Go toTop